• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环状 RNA-VANGL1 通过吸附 miRNA-217 调控 RUNX2 表达促进骨质疏松进展。

Circ-VANGL1 promotes the progression of osteoporosis by absorbing miRNA-217 to regulate RUNX2 expression.

机构信息

Department of Orthopedics, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.

出版信息

Eur Rev Med Pharmacol Sci. 2019 Feb;23(3):949-957. doi: 10.26355/eurrev_201902_16981.

DOI:10.26355/eurrev_201902_16981
PMID:30779060
Abstract

OBJECTIVE

This study aims to investigate whether circ-VANGL1 can promote the progression of osteoporosis (OP) by absorbing miRNA-217 to regulate RUNX2 expression.

PATIENTS AND METHODS

The serum levels of circ-VANGL1, miRNA-217 and RUNX2 in OP patients and non-OP patients were detected by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). Their expression levels in human bone marrow mesenchymal stem cells (hBMSCs) at different time points of osteogenesis differentiation were determined as well. The expression levels of RUNX2 and osteogenic proteins (BSP, OCN, OPN) in hBMSCs were detected by Western blot. Dual-Luciferase reporter gene assay was performed to verify the relationship among circ-VANGL1, miRNA-217 and RUNX2. Alkaline phosphatase (ALP) staining was conducted to evaluate the degree of osteogenic differentiation influenced by circ-VANGL1 and miRNA-217.

RESULTS

OP patients presented a higher serum level of miRNA-217 and lower serum levels of circ-VANGL1 and RUNX2 relative to non-OP patients. Circ-VANGL1 accelerated osteogenic differentiation by absorbing miRNA-217 to regulate RUNX2 expression. Moreover, miRNA-217 inhibited osteogenic differentiation by degrading RUNX2 by targeting to RUNX2 3'UTR. The overexpression of circ-VANGL1 upregulated expressions of RUNX2, BSP, OCN, and OPN. Meanwhile, ALP activity increased in hBMSCs overexpressing circ-VANGL1. However, co-overexpression of circ-VANGL1 and miRNA-217 did not alter RUNX2 expression. ALP activity in hBMSCs co-overexpressing circ-VANGL1 and miRNA-217 slightly increased, but had no difference with controls.

CONCLUSIONS

Circ-VANGL1 promotes the development of OP via binding to miRNA-217 to downregulate RUNX2 expression.

摘要

目的

本研究旨在探讨环状 RNA 血管生成素样 1(circ-VANGL1)是否通过吸收 miRNA-217 来调节 runt 相关转录因子 2(RUNX2)的表达,从而促进骨质疏松症(OP)的进展。

方法

采用实时定量聚合酶链反应(qRT-PCR)检测 OP 患者和非 OP 患者血清中 circ-VANGL1、miRNA-217 和 RUNX2 的水平,并检测不同成骨分化时间点人骨髓间充质干细胞(hBMSCs)中它们的表达水平。Western blot 检测 hBMSCs 中 RUNX2 和成骨蛋白(BSP、OCN、OPN)的表达水平。双荧光素酶报告基因实验验证 circ-VANGL1、miRNA-217 和 RUNX2 之间的关系。碱性磷酸酶(ALP)染色评估 circ-VANGL1 和 miRNA-217 对成骨分化程度的影响。

结果

OP 患者血清中 miRNA-217 水平升高,circ-VANGL1 水平降低,RUNX2 水平降低。circ-VANGL1 通过吸收 miRNA-217 调节 RUNX2 表达,加速成骨分化。此外,miRNA-217 通过靶向 RUNX2 3'UTR 降解 RUNX2 抑制成骨分化。circ-VANGL1 的过表达上调 RUNX2、BSP、OCN 和 OPN 的表达。同时,hBMSCs 中转录物 circ-VANGL1 过表达后 ALP 活性增加。然而,circ-VANGL1 与 miRNA-217 的共过表达并没有改变 RUNX2 的表达。hBMSCs 中转录物 circ-VANGL1 与 miRNA-217 共过表达后 ALP 活性略有增加,但与对照组无差异。

结论

circ-VANGL1 通过与 miRNA-217 结合下调 RUNX2 表达,促进 OP 的发展。

相似文献

1
Circ-VANGL1 promotes the progression of osteoporosis by absorbing miRNA-217 to regulate RUNX2 expression.环状 RNA-VANGL1 通过吸附 miRNA-217 调控 RUNX2 表达促进骨质疏松进展。
Eur Rev Med Pharmacol Sci. 2019 Feb;23(3):949-957. doi: 10.26355/eurrev_201902_16981.
2
MiRNA-365a-3p promotes the progression of osteoporosis by inhibiting osteogenic differentiation via targeting RUNX2.miRNA-365a-3p 通过靶向 RUNX2 抑制成骨分化促进骨质疏松症的进展。
Eur Rev Med Pharmacol Sci. 2019 Sep;23(18):7766-7774. doi: 10.26355/eurrev_201909_18986.
3
MiRNA-19a-3p alleviates the progression of osteoporosis by targeting HDAC4 to promote the osteogenic differentiation of hMSCs.miRNA-19a-3p 通过靶向 HDAC4 促进 hMSCs 的成骨分化来缓解骨质疏松症的进展。
Biochem Biophys Res Commun. 2019 Aug 27;516(3):666-672. doi: 10.1016/j.bbrc.2019.06.083. Epub 2019 Jun 24.
4
LncRNA TERC alleviates the progression of osteoporosis by absorbing miRNA-217 to upregulate RUNX2.长链非编码 RNA TERC 通过吸附 miRNA-217 来上调 RUNX2 从而减轻骨质疏松的进展。
Eur Rev Med Pharmacol Sci. 2020 Jan;24(2):526-534. doi: 10.26355/eurrev_202001_20029.
5
LncRNA XIXT promotes osteogenic differentiation of bone mesenchymal stem cells and alleviates osteoporosis progression by targeting miRNA-30a-5p.长链非编码 RNA XIXT 通过靶向 miRNA-30a-5p 促进骨髓间充质干细胞的成骨分化并缓解骨质疏松症的进展。
Eur Rev Med Pharmacol Sci. 2019 Oct;23(20):8721-8729. doi: 10.26355/eurrev_201910_19266.
6
MicroRNA-579-3p promotes the progression of osteoporosis by inhibiting osteogenic differentiation of mesenchymal stem cells through regulating Sirt1.微小 RNA-579-3p 通过调节 Sirt1 抑制间充质干细胞的成骨分化,促进骨质疏松的进展。
Eur Rev Med Pharmacol Sci. 2019 Aug;23(16):6791-6799. doi: 10.26355/eurrev_201908_18717.
7
Teriparatide alleviates osteoporosis by promoting osteogenic differentiation of hMSCs via miR-375/RUNX2 axis.特立帕肽通过 miR-375/RUNX2 轴促进 hMSCs 的成骨分化来缓解骨质疏松症。
Eur Rev Med Pharmacol Sci. 2019 Dec;23(24):11043-11050. doi: 10.26355/eurrev_201912_19812.
8
CircRUNX2 through has-miR-203 regulates RUNX2 to prevent osteoporosis.环状 RNA RUNX2 通过靶向 miR-203 调控 RUNX2 表达预防骨质疏松症。
J Cell Mol Med. 2018 Dec;22(12):6112-6121. doi: 10.1111/jcmm.13888. Epub 2018 Oct 16.
9
Circ_0019693 promotes osteogenic differentiation of bone marrow mesenchymal stem cell and enhances osteogenesis-coupled angiogenesis via regulating microRNA-942-5p-targeted purkinje cell protein 4 in the development of osteoporosis.Circ_0019693 通过调控微小 RNA-942-5p 靶向的小脑浦肯野细胞蛋白 4 促进骨髓间充质干细胞成骨分化并增强成骨耦联血管生成在骨质疏松症的发生发展中。
Bioengineered. 2022 Feb;13(2):2181-2193. doi: 10.1080/21655979.2021.2023982.
10
MicroRNA-1286 inhibits osteogenic differentiation of mesenchymal stem cells to promote the progression of osteoporosis via regulating FZD4 expression.微小 RNA-1286 通过调控 FZD4 的表达抑制间充质干细胞的成骨分化从而促进骨质疏松症的进展。
Eur Rev Med Pharmacol Sci. 2020 Jan;24(1):1-10. doi: 10.26355/eurrev_202001_19889.

引用本文的文献

1
A Novel Bioimplant Comprising Ad-BMP9-Transfected BMSCs and GelMA Microspheres Produced from Microfluidic Devices for Bone Tissue Engineering.一种用于骨组织工程的新型生物植入物,其由腺病毒介导的骨形态发生蛋白9转染的骨髓间充质干细胞和微流控装置制备的甲基丙烯酰化明胶微球组成。
J Tissue Eng Regen Med. 2023 Jun 19;2023:2981936. doi: 10.1155/2023/2981936. eCollection 2023.
2
Research progress of circRNAs in bone-related diseases.环状RNA在骨相关疾病中的研究进展
Front Oncol. 2025 Jan 27;15:1481322. doi: 10.3389/fonc.2025.1481322. eCollection 2025.
3
Exploring the Role of Circular RNA in Bone Biology: A Comprehensive Review.
探索环状 RNA 在骨生物学中的作用:全面综述。
Cells. 2024 Jun 7;13(12):999. doi: 10.3390/cells13120999.
4
Circ_0003764 Regulates the Osteogenic Differentiation of Periodontal Ligament Stem Cells.环状 RNA 0003764 调控牙周膜干细胞的成骨分化。
Int Dent J. 2024 Oct;74(5):1110-1119. doi: 10.1016/j.identj.2024.03.004. Epub 2024 Mar 28.
5
Regulatory mechanisms of circular RNAs during human mesenchymal stem cell osteogenic differentiation.环状 RNA 在人骨髓间充质干细胞成骨分化过程中的调控机制。
Theranostics. 2024 Jan 1;14(1):143-158. doi: 10.7150/thno.89066. eCollection 2024.
6
MiR-217 Regulates SIRT1 Expression and Promotes Inflammatory and Apoptotic Responses in Osteoarthritis.miR-217 调节 SIRT1 表达并促进骨关节炎中的炎症和凋亡反应。
Genes (Basel). 2023 Nov 29;14(12):2155. doi: 10.3390/genes14122155.
7
Common miRNAs of Osteoporosis and Fibromyalgia: A Review.骨质疏松症和纤维肌痛的常见 miRNA:综述。
Int J Mol Sci. 2023 Aug 31;24(17):13513. doi: 10.3390/ijms241713513.
8
Circular RNAs: Promising Targets in Osteoporosis.环状 RNA:骨质疏松症的有前途靶点。
Curr Osteoporos Rep. 2023 Jun;21(3):289-302. doi: 10.1007/s11914-023-00786-7. Epub 2023 Apr 29.
9
Comprehensive analysis of epigenetics mechanisms in osteoporosis.骨质疏松症表观遗传机制的综合分析
Front Genet. 2023 Mar 28;14:1153585. doi: 10.3389/fgene.2023.1153585. eCollection 2023.
10
Sharing Circulating Micro-RNAs between Osteoporosis and Sarcopenia: A Systematic Review.骨质疏松症与肌肉减少症之间循环微小RNA的共享:一项系统综述
Life (Basel). 2023 Feb 21;13(3):602. doi: 10.3390/life13030602.